Cancer Clinical Trials in Atlanta, Georgia

8 studies are recruiting for cancer in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Connect for Cancer Prevention Study (Connect)

   Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of pe…

   Stage

   Not phased

   Ages

   30 to 70

   Site

   Kaiser Permanente Georgia, Atlanta, Georgia

   Locations

   10 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT04609072 on ClinicalTrials.gov

2. Childhood Cancer Survivor Study

   The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximate…

   Stage

   Not phased

   Ages

   Any age

   Site

   Emory University/Children's Health Care of Atlanta, Atlanta, Georgia

   Locations

   31 in total

   Run by

   St. Jude Children's Research Hospital

   See if you can join NCT01120353 on ClinicalTrials.gov

3. Galleri® in the Medicare Population.

   This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.

   Stage

   Not phased

   Ages

   50 and older

   Site

   Morehouse School of Medicine Atlanta, Atlanta, Georgia

   Locations

   61 in total

   Run by

   GRAIL, Inc.

   See if you can join NCT05673018 on ClinicalTrials.gov

4. Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

   This is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at one 1 or more dosi…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Winship Cancer Institute, Emory University, Atlanta, Georgia

   Locations

   17 in total

   Run by

   MBrace Therapeutics

   See if you can join NCT06014658 on ClinicalTrials.gov

5. TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

   This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.

   Stage

   Not phased

   Ages

   18 to 99

   Site

   Morehouse, Atlanta, Georgia

   Locations

   32 in total

   Run by

   Tempus AI

   See if you can join NCT06207032 on ClinicalTrials.gov

6. Caris Biorepository Research Protocol

   The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collecte…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Emory University, Atlanta, Georgia

   Locations

   38 in total

   Run by

   Caris Science, Inc.

   See if you can join NCT01499394 on ClinicalTrials.gov

7. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

   International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

   Stage

   Not phased

   Ages

   Any age

   Site

   Massive Bio SYNERGY-AI site, Atlanta, Georgia

   Locations

   68 in total

   Run by

   Massive Bio, Inc.

   See if you can join NCT03452774 on ClinicalTrials.gov

8. Morehouse Total Cancer Care Protocol

   The overall objective of the Morehouse Total Cancer Care study is to develop an improved standard of cancer care by facilitating new biomarker and drug target discovery, informatics solutions, clinical trials, and "personalized medicine" for our community oncology partners (i.e., community hospital…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Morehouse School of Medicine, Atlanta, Georgia

   Run by

   Morehouse School of Medicine

   See if you can join NCT04804878 on ClinicalTrials.gov